Hospira Misled Investors To Pump Up Stock Prices: Suit

Law360, New York (December 9, 2011, 9:05 PM EST) -- A pension plan lodged a putative class action Thursday in Illinois federal court accusing cancer drug maker Hospira Inc. and three executives of artificially inflating stock prices in part by withholding information about a regulatory probe into drug production and other activities.

IUE-CWA Local 475 Pension Plan alleges the specialty medication company sugarcoated two U.S. Food and Drug Administration investigations of its production of cancer drugs and infusion pumps and made misleading statements about the company's overall financial health.

These practices artificially bolstered the prices of...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

IUE-CWA Local 475 Pension Plan v. Hospira, Inc. et al


Case Number

1:11-cv-08746

Court

Illinois Northern

Nature of Suit

850(Securities/Commodities)

Judge

Honorable Amy J. St. Eve

Date Filed

December 9, 2011

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.